Securities code: 002868 securities abbreviation: Lifecome Biochemistry Co.Ltd(002868) Announcement No.: 2022-009 Lifecome Biochemistry Co.Ltd(002868)
With regard to the announcement of the resolution of the first extraordinary general meeting of shareholders in 2022, the company and all members of the board of directors guarantee that the content of information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.
Special tips:
1. There was no increase, rejection or change of proposals during the shareholders’ meeting.
2. The general meeting of shareholders adopts the combination of on-site voting and online voting. 1、 Meetings held
1. Notice of meeting
Lifecome Biochemistry Co.Ltd(002868) (hereinafter referred to as “the company” or ” Lifecome Biochemistry Co.Ltd(002868) “) was published in Securities Daily and cninfo on January 18, 2022（ http://www.cn.info.com.cn. ）The announcement on the notice of convening the first extraordinary general meeting of shareholders in 2022 (Announcement No.: 2022-005) was published. 2. Meeting time
On site meeting time: from 15:00 p.m. on Monday, February 7, 2022.
Online voting time: February 7, 2022. The specific time of online voting through the trading system of Shenzhen stock exchange is 9:15-9:25, 9:30-11:30 and 13:00-15:00 on February 7, 2022; The specific time of voting through the Internet voting system of Shenzhen stock exchange is any time from 9:15 to 15:00 on February 7, 2022.
3. Venue of on-site meeting: conference room 1 on the second floor of the company’s comprehensive office building
4. Convener: Board of directors
5. Meeting mode: the combination of on-site voting and online voting
6. Host of the on-site meeting: Mr. Lai Tanping, chairman of the company
7. The convening and convening of the meeting shall comply with the company law, the rules for the general meeting of shareholders of listed companies, the rules for the listing of shares, the articles of association and other relevant provisions. 2、 Attendance at the meeting
General attendance of shareholders:
There are 7 shareholders voting on site and online, representing 67241710 shares, accounting for 43.2657% of the total shares of the listed company.
Among them, 4 shareholders voted on the spot, representing 67206460 shares, accounting for 43.2430% of the total shares of the listed company.
Three shareholders voted online, representing 35250 shares, accounting for 0.0227% of the total shares of the listed company.
Overall attendance of minority shareholders:
Five minority shareholders voted on the spot and online, representing 14753850 shares, accounting for 9.4931% of the total shares of the listed company.
Among them, there are 2 minority shareholders voting on site, representing 14718600 shares, accounting for 9.4705% of the total shares of the listed company.
Three minority shareholders voted online, representing 35250 shares, accounting for 0.0227% of the total shares of the listed company. 3、 Deliberation and voting of proposal 1.00 general voting of proposal 1.00 proposal on requesting the general meeting of shareholders to agree to extend the validity period of the resolution of the general meeting of shareholders of non-public development of A-Shares of the company and the validity period of the general meeting of shareholders authorizing the board of directors and authorized persons of the board of directors to handle relevant matters:
67238460 shares were approved, accounting for 99.9952% of the shares held by all shareholders attending the meeting; Against 3250 shares, accounting for 0.0048% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting. Total voting of minority shareholders:
Agreed to 14750600 shares, accounting for 99.9780% of the shares held by minority shareholders attending the meeting; Against 3250 shares, accounting for 0.0220% of the shares held by minority shareholders attending the meeting; Abstained 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting
4、 Lawyer witness
Affected by the epidemic of pneumonia caused by New Coronavirus, the shareholders’ meeting was witnessed by the lawyer of the law firm in Shanghai through the video method, and a legal opinion was issued. It was considered that the convening and convening procedures of the shareholders’ meeting were in conformity with the relevant laws, regulations, normative documents and the provisions of the articles of association. The qualifications of the personnel attending the meeting are legal and valid, and the voting procedures and voting results of the general meeting of shareholders are legal and valid. 5、 Documents for future reference
1. Resolution of Lifecome Biochemistry Co.Ltd(002868) the first extraordinary general meeting of shareholders in 2022
2. Legal opinion on the first extraordinary general meeting of shareholders in Lifecome Biochemistry Co.Ltd(002868) 2022 issued by Shanghai Chengming Zezheng law firm
It is hereby announced.
Lifecome Biochemistry Co.Ltd(002868) board of directors
February 7, 2002
